Target intelligence / Profile preview

C-type lectin domain family 1 member A (CLEC1A)

Target
CLEC1A
Molecular classification
C-type lectin domain-containing protein, Receptor, Cell surface protein
01

Overview

C-type lectin domain family 1 member A is a cell surface protein encoded by the CLEC1A gene in humans. As a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily, this protein is characterized by its ability to bind carbohydrates in a calcium-dependent manner. CLEC1A participates in a variety of functions including regulation of dendritic cell activity, immune response, cell adhesion, cell signaling, and control of glycoprotein turnover[1][5][6][8]. It is located in the natural killer gene complex on chromosome 12p13 and may function in modulating inflammation and immune-mediated responses. No clinically approved drugs or established biomarkers for CLEC1A are reported, and therapeutic targeting efforts are largely preclinical.

Other names
CLEC-1CLEC1CLEC1A protein
02

Mechanism of action

Carbohydrate binding (as a member of the C-type lectin domain superfamily)[6]. Negative regulation of inflammatory response (based on murine/CLEC1A studies)[5].

03

Biological functions

Immune responseCell adhesionCell-cell signallingGlycoprotein turnoverRegulation of dendritic cell functionInflammation
04

Disease associations

InflammationInfectionOther (potential involvement in immune-mediated diseases; specific roles in cancer or neurodegenerative disease are not directly established in current sources)
05

Safety considerations

Limited data available; no specific safety concerns are currently documented in literature

Beyond the preview

Go deeper on C-type lectin domain family 1 member A (CLEC1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-type lectin domain family 1 member A (CLEC1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call